| Tolerability and efficacy study of P2X7 inhibition in experimental Charcot-Marie-Tooth type 1A (CMT1A) neuropathy G Sociali, D Visigalli, T Prukop, I Cervellini, E Mannino, C Venturi, ... Neurobiology of Disease 95, 145-157, 2016 | 36 | 2016 |
| PMP22 messenger RNA levels in skin biopsies: testing the effectiveness of a Charcot–Marie–Tooth 1A biomarker L Nobbio, D Visigalli, D Radice, E Fiorina, A Solari, G Lauria, MM Reilly, ... Brain 137 (6), 1614-1620, 2014 | 36 | 2014 |
| Sphingomyelin as a myelin biomarker in CSF of acquired demyelinating neuropathies G Capodivento, D Visigalli, M Garnero, R Fancellu, MD Ferrara, A Basit, ... Scientific reports 7 (1), 7831, 2017 | 33 | 2017 |
| Hind limb unloading of mice modulates gene expression at the protein and mRNA level in mesenchymal bone cells D Visigalli, A Strangio, D Palmieri, P Manduca BMC Musculoskeletal Disorders 11, 1-13, 2010 | 33 | 2010 |
| CSF sphingomyelin: a new biomarker of demyelination in the diagnosis and management of CIDP and GBS G Capodivento, C De Michelis, M Carpo, R Fancellu, E Schirinzi, D Severi, ... Journal of Neurology, Neurosurgery & Psychiatry 92 (3), 303-310, 2021 | 27 | 2021 |
| Oxydative phosphorylation in sciatic nerve myelin and its impairment in a model of dysmyelinating peripheral neuropathy S Ravera, L Nobbio, D Visigalli, M Bartolucci, D Calzia, F Fiorese, ... Journal of neurochemistry 126 (1), 82-92, 2013 | 24 | 2013 |
| The diadenosine homodinucleotide P18 improves in vitro myelination in experimental Charcot‐Marie‐tooth type 1A L Nobbio, D Visigalli, E Mannino, F Fiorese, MU Kassack, L Sturla, ... Journal of Cellular Biochemistry 115 (1), 161-167, 2014 | 16 | 2014 |
| The carboxyl terminal trimer of procollagen I induces pro-metastatic changes and vascularization in breast cancer cells xenografts D Visigalli, D Palmieri, A Strangio, S Astigiano, O Barbieri, G Casartelli, ... BMC cancer 9, 1-10, 2009 | 16 | 2009 |
| Exploiting sphingo-and glycerophospholipid impairment to select effective drugs and biomarkers for CMT1A D Visigalli, G Capodivento, A Basit, R Fernández, Z Hamid, B Pencová, ... Frontiers in Neurology 11, 534482, 2020 | 14 | 2020 |
| Alternative Splicing in the Human PMP22 Gene: Implications in CMT1A Neuropathy D Visigalli, P Castagnola, G Capodivento, A Geroldi, E Bellone, ... Human Mutation 37 (1), 98-109, 2016 | 12 | 2016 |
| Case Report: Post-COVID-19 Vaccine Recurrence of Guillain–Barré Syndrome Following an Antecedent Parainfectious COVID-19–Related GBS M Bellucci, F Germano, S Grisanti, C Castellano, F Tazza, EM Mobilia, ... Frontiers in immunology 13, 894872, 2022 | 11 | 2022 |
| Soluble Neuregulin1 is strongly up-regulated in the rat model of Charcot-Marie-Tooth 1A disease BE Fornasari, G Ronchi, D Pascal, D Visigalli, G Capodivento, L Nobbio, ... Experimental Biology and Medicine 243 (4), 370-374, 2018 | 11 | 2018 |
| COVID-19-associated serum and cerebrospinal fluid cytokines in post-versus para-infectious SARS-CoV-2-related Guillain–Barré syndrome F Massa, T Vigo, M Bellucci, D Giunti, MM Emanuela, D Visigalli, ... Neurological Sciences, 1-11, 2024 | 1 | 2024 |
| Monitoring myelin lipid composition and structure of myelinated fibers reveals a maturation delay in CMT1A G Capodivento, M Camera, N Liessi, A Trada, D Debellis, A Schenone, ... bioRxiv, 2024.03. 08.581205, 2024 | | 2024 |
| POST-COVID-19 VACCINE RELAPSE OF GUILLAIN-BARRE SYNDROME (GBS) FOLLOWING AN ANTECEDENT PARA-INFECTIOUS COVID-19-RELATED GBS: A CASE REPORT M Bellucci, F Germano, S Grisanti, C Castellano, F Tazza, EM Mobilia, ... Journal of the Peripheral Nervous System, S5-S6, 2022 | | 2022 |
| SUPPLEMENTAL INFORMATION FOR G Capodivento, C De Michelis, M Carpo, R Fancellu, E Schirinzi, D Severi, ... J Neurol Neurosurg Psychiatry 303, 92, 2021 | | 2021 |
| Sphingomyelin: A novel CSF biomarker for the management of acquired demyelinating neuropathies G Capodivento, C De Michelis, M Carpo, R Fancellu, E Schirinzi, D Severi, ... JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 25 (4), 497-498, 2020 | | 2020 |
| SPHINGOMYELIN DOSAGE IN GBS/CIDP PATIENTS: BIOMARKER VALIDATION IN A MULTICENTER, PROSPECTIVE STUDY G Capodivento, C De Michelis, D Visigalli, E Capello, A Schenone, ... JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 24, S9-S9, 2019 | | 2019 |
| CSF Sphingomyelin concentration: A myelin biomarker for acquired demyelinating neuropathies L Nobbio, G Capodivento, D Visigalli, M Garnero, R Fancellu, A Armirotti, ... JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 23 (4), 324-324, 2018 | | 2018 |
| LIPID ARCHITECTURE IN CHARCOT-MARIE-TOOTH TYPE 1A RAT SCIATIC NERVE USING IMAGING MASS SPECTROMETRY G Capodivento, B Pencova, D Visigalli, R Fernandez, D Marubbi, ... JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM 23, S8-S8, 2018 | | 2018 |
Angelo SchenoneProfessor of Neurology, University of GenovaVerified email at neurologia.unige.it
